CoChat

Resolving the cause of recurrent Plasmodium vivax malaria probabilistically

Taylor, Aimee R., Watson, James A., Chu, Cindy S., Puaprasert, Kanokpich, Duanguppama, Jureeporn, Day, Nicholas P. J., Nosten, Francois, Neafsey, Daniel E., Buckee, Caroline O., Imwong, Mallika, White, Nicholas J. · 2019 · Nature Communications
Cited by 118

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Relapses arising from dormant liver-stage Plasmodium vivax parasites (hypnozoites) are a major cause of vivax malaria. However, in endemic areas, a recurrent blood-stage infection following treatment can be hypnozoite-derived (relapse), a blood-stage treatment failure (recrudescence), or a newly acquired infection (reinfection). Each of these requires a different prevention strategy, but it was not previously possible to distinguish between them reliably. We show that individual vivax malaria recurrences can be characterised probabilistically by combined modelling of time-to-event and genetic data within a framework incorporating identity-by-descent. Analysis of pooled patient data on 1441 recurrent P. vivax infections in 1299 patients on the Thailand–Myanmar border observed over 1000 patient follow-up years shows that, without primaquine radical curative treatment, 3 in 4 patients relapse. In contrast, after supervised high-dose primaquine only 1 in 40 relapse. In this region of frequent relapsing P. vivax , failure rates after supervised high-dose primaquine are significantly lower (∼3%) than estimated previously.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13412-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 36

  1. Howes, R. E. et al. Global epidemiology of Plasmodium vivax. Am. J. Trop. Med. Hyg. 95, 15–34 (2016). · DOI · Paper page
  2. Coatney, G. R., Cooper, W. C. & Young, M. D. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J. Natl. Malar. Soc. 9, 381–96 (1950).
  3. White, N. J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 10, 297 (2011). · DOI · Paper page
  4. Battle, K. E. et al. Geographical variation in Plasmodium vivax relapse. Malar. J. 13, 144 (2014). · DOI · Paper page
  5. Messerli, C., Hofmann, N. E., Beck, H.-P. & Felger, I. Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers. Antimicrob. Agents Chemother. 61, e01500–e01516 (2017). · DOI
  6. Mwingira, F. et al. Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Malaria J. 10, 1–10 (2011). · DOI · Paper page
  7. Baton, L. A. & Ranford-Cartwright, L. C. Spreading the seeds of million-murdering death: metamorphoses of malaria in the mosquito. Trends Parasitol. 21, 573–580 (2005). · doi:10.1016/j.pt.2005.09.012
  8. Imwong, M. et al. The first Plasmodium vivax relapses of life are usually genetically homologous. J. Infect. Dis. 205, 680–683 (2012). · DOI · Paper page
  9. Imwong, M. et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195, 927–33 (2007). · DOI · Paper page
  10. Chen, N., Auliff, A., Rieckmann, K. & Cheng, Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195, 934–941 (2007). · DOI · Paper page
  11. Restrepo, E., Imwong, M., Rojas, W., Carmona-Fonseca, J. & Maestre, A. High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia. Acta Trop. 119, 23–29 (2011). · DOI
  12. de Araujo, F. C., de Rezende, A. M., Fontes, C. J., Carvalho, L. H. & Alves de Brito, C. F. Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection. PLoS ONE 7, e49871 (2012). · doi:10.1371/journal.pone.0049871
  13. Maneerattanasak, S. et al. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes. Malaria J. 16, 228 (2017). · DOI
  14. Popovici, J. et al. Genomic analyses reveal the common occurrence and complexity of Plasmodium vivax relapses in Cambodia. mBio 9, e01888–e01917 (2018). · DOI
  15. Chu, C. S. et al. Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin. Infect. Dis. 67, 1543–1549 (2018). · DOI · Paper page
  16. Chu, C. S. et al. Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in Plasmodium vivax malaria. Clin. Infect. Dis. 68, 1311–1319 (2018). · DOI
  17. Adekunle, A. I. et al. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo. PLoS Negl. Trop. Dis. 9, e0003595 (2015). · DOI · Paper page
  18. White, M. T. et al. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission. Elife 3, e04692 (2014). · DOI · Paper page
  19. Landier, J. et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet 391, 1916–1926 (2018). · DOI · Paper page
  20. Llanos-Cuentas, A. et al. Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria. N. Engl. J. Med. 380, 229–241 (2019). · DOI · Paper page
  21. Lacerda, M. V. et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N. Engl. J. Med. 380, 215–228 (2019). · DOI · Paper page
  22. White, M. T., Shirreff, G., Karl, S., Ghani, A. C. & Mueller, I. Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. Proc. R. Soc. B 283, 00–48 (2016). · DOI
  23. White, M. T. et al. Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax. Nat. Commun. 9, 3300 (2018). · DOI
  24. Zhu, S. J. et al. The origins and relatedness structure of mixed infections vary with local prevalence of P. falciparum malaria. eLife 8, e40845 (2019). · DOI
  25. Barry, A. E., Waltmann, A., Koepfli, C., Barnadas, C. & Mueller, I. Uncovering the transmission dynamics of Plasmodium vivax using population genetics. Pathog. Glob. Health 109, 142–152 (2015). · doi:10.1179/2047773215y.0000000012
  26. Pearson, R. D. et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat. Genet. 48, 959–964 (2016). · DOI · Paper page
  27. Hupalo, D. N. et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nat. Genet. 48, 953–958 (2016). · DOI · Paper page
  28. Ross, A. et al. The incidence and differential seasonal patterns of plasmodium vivax primary infections and relapses in a cohort of children in papua new guinea. PLoS Negl. Trop. Dis. 10, e0004582 (2016). · DOI · Paper page
  29. White, M. T. et al. Plasmodium vivax and plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses. Malar. J. 17, 170 (2018). · DOI
  30. Gattepaille, L. M. & Jakobsson, M. Combining markers into haplotypes can improve population structure inference. Genetics 190, 159–174 (2012). · DOI
  31. Baetscher, D. S., Clemento, A. J., Ng, T. C., Anderson, E. C. & Garza, J. C. Microhaplotypes provide increased power from short-read DNA sequences for relationship inference. Mol. Ecol. Resour. 18, 296–305 (2018). · DOI
  32. Wang, J. & Scribner, K. T. Parentage and sibship inference from markers in polyploids. Mol. Ecol. Resour. 14, 541–553 (2014). · DOI
  33. Gunawardena, S. et al. Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia. Am. J. Trop. Med. Hyg. 82, 235–242 (2010). · DOI
  34. Taylor, A. R., Jacob, P. E., Neafsey, D. E. & Buckee, C. O. Estimating relatedness between malaria parasites. Genetics 212, 1337–1351 (2019). · DOI · Paper page
  35. Hoffman, J. I. & Amos, W. Microsatellite genotyping errors: detection approaches, common sources and consequences for paternal exclusion. Mol. Ecol. 14, 599–612 (2005). · DOI · Paper page
  36. Csardi, G. & Nepusz, T. The igraph software package for complex network research. Inter J. Complex Syst. 1695, 1–9 (2006).

Cited by

See all 118

Metadata

Authors
Taylor, A. R., Watson, J. A., Chu, C. S., Puaprasert, K., Duanguppama, J., Day, N. P. J., Nosten, F., Neafsey, D. E., Buckee, C. O., Imwong, M., & White, N. J.
Venue
Nature Communications
Published
2019-12-06
Volume
10
Issue
1
ISSN
2041-1723
Cited by
118
References
5
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM12471502)
  • Thailand Research Fund (PHD/0032/2556)
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI110818)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. https://app.cochat.ai/papers/10.1038/s41467-019-13412-x
The paper
Taylor, A. R., Watson, J. A., Chu, C. S., Puaprasert, K., Duanguppama, J., Day, N. P. J., Nosten, F., Neafsey, D. E., Buckee, C. O., Imwong, M., & White, N. J. (2019). Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nature Communications. https://doi.org/10.1038/s41467-019-13412-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.